[TLX] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Jun-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 2,390.91%
YoY- 2,390.91%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 30/06/15 30/09/00 CAGR
Revenue 49 0 0 0 0 0 0 -
PBT -4,806 -3,143 -1,594 1,550 -66 -66 -249 18.70%
Tax -471 -76 -38 24 -8 -8 -249 3.76%
NP -4,806 -3,143 -1,556 1,512 -66 -66 -497 14.04%
Tax Rate - - - -1.54% - - - -
Total Cost 4,854 3,143 1,556 -1,512 66 66 497 14.11%
Ratio Analysis
31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 30/06/15 30/09/00 CAGR
NP Margin -9,850.62 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/17 30/06/17 31/01/17 30/06/16 31/12/15 30/06/15 30/09/00 CAGR
EPS -0.02 -1.28 -0.01 0.01 0.00 0.00 -0.01 4.09%
EPS Diluted -0.02 -1.28 -0.01 0.01 0.00 0.00 -0.01 4.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.